Manuela A. Bergmann

1.1k total citations
11 papers, 592 citations indexed

About

Manuela A. Bergmann is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Manuela A. Bergmann has authored 11 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 6 papers in Immunology. Recurrent topics in Manuela A. Bergmann's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Manuela A. Bergmann is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Manuela A. Bergmann collaborates with scholars based in Germany, Austria and Switzerland. Manuela A. Bergmann's co-authors include Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer, Raymonde Busch, Bertold Emmerich, Kirsten Fischer, Clemens‐Martin Wendtner, Hartmut Döhner, Martin Wilhelm and Anna‐Maria Fink and has published in prestigious journals such as Blood and PubMed.

In The Last Decade

Manuela A. Bergmann

11 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manuela A. Bergmann Germany	6	562	502	239	104	96	11	592
R. F. Bezares Argentina	3	516 0.9×	438 0.9×	250 1.0×	97 0.9×	86 0.9×	5	555
Владимир Стругов Russia	4	466 0.8×	392 0.8×	167 0.7×	124 1.2×	74 0.8×	12	485
Julia von Tresckow Germany	9	333 0.6×	303 0.6×	128 0.5×	92 0.9×	58 0.6×	35	391
Joi Ninomoto United States	11	376 0.7×	300 0.6×	118 0.5×	148 1.4×	51 0.5×	19	407
Geisler Ch Denmark	5	357 0.6×	291 0.6×	186 0.8×	73 0.7×	19 0.2×	6	388
Polina Kaplan Poland	6	283 0.5×	228 0.5×	94 0.4×	116 1.1×	39 0.4×	9	331
A. Copplestone United Kingdom	7	375 0.7×	239 0.5×	209 0.9×	144 1.4×	19 0.2×	13	486
Talha Munir United Kingdom	5	331 0.6×	264 0.5×	135 0.6×	97 0.9×	46 0.5×	16	365
A Alcalá Spain	10	195 0.3×	187 0.4×	88 0.4×	215 2.1×	50 0.5×	11	407
Thérèse Aurran France	8	202 0.4×	178 0.4×	80 0.3×	40 0.4×	23 0.2×	19	257

Countries citing papers authored by Manuela A. Bergmann

Since Specialization

Citations

This map shows the geographic impact of Manuela A. Bergmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela A. Bergmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela A. Bergmann more than expected).

Fields of papers citing papers by Manuela A. Bergmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela A. Bergmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela A. Bergmann. The network helps show where Manuela A. Bergmann may publish in the future.

Co-authorship network of co-authors of Manuela A. Bergmann

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela A. Bergmann. A scholar is included among the top collaborators of Manuela A. Bergmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela A. Bergmann. Manuela A. Bergmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Goede, Valentin, Jasmin Bahlo, Nadine Kutsch, et al.. (2016). Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) in Elderly Patients with Comorbidities: Analysis of the CLL11 Study Population. Blood. 128(22). 4401–4401. 7 indexed citations

Al‐Sawaf, Othman, Sandra Robrecht, Jasmin Bahlo, et al.. (2016). Impact of Gender on Outcome after Chemoimmunotherapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) or Bendamustine Plus Rituximab (BR) in Patients with Chronic Lymphocytic Leukemia (CLL): A Meta-Analysis of Three Phase II/III Studies of the German CLL Study Group (GCLLSG). Blood. 128(22). 4394–4394. 2 indexed citations

Pflug, Natali, Jasmin Bahlo, Tait D. Shanafelt, et al.. (2014). Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia. Blood. 124(1). 49–62. 182 indexed citations

Seiler, Till, Roland C. Aydin, Tobias Herold, et al.. (2013). Alterations Of The Chemokine Microenvironment In Chronic Lymphocytic Leukemia. Blood. 122(21). 1619–1619. 1 indexed citations

Bergmann, Manuela A., Raymonde Busch, Barbara Eichhorst, et al.. (2013). Overall Survival In Early Stage Chronic Lymphocytic Leukemia Patients With Treatment Indication Due To Disease Progression: Follow-Up Data Of The CLL1 Trial Of The German CLL Study Group (GCLLSG). Blood. 122(21). 4127–4127. 5 indexed citations

Schweighofer, Carmen D., Florence Cymbalista, Carolin Müller, et al.. (2013). Early Versus Deferred Treatment With Combined Fludarabine, Cyclophosphamide and Rituximab (FCR) Improves Event-Free Survival In Patients With High-Risk Binet Stage A Chronic Lymphocytic Leukemia – First Results Of a Randomized German-French Cooperative Phase III Trial. Blood. 122(21). 524–524. 30 indexed citations

Cramer, Paula, Susanne Isfort, Jasmin Bahlo, et al.. (2012). The Use of Chemoimmunotherapy Improves the Outcome of Patients with Chronic Lymphocytic Leukaemia (CLL) – a Metaanalysis of Five Trials of the German CLL Study Group (GCLLSG). Blood. 120(21). 3936–3936. 2 indexed citations

Eichhorst, Barbara, Raymonde Busch, Stephan Stilgenbauer, et al.. (2009). First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. Blood. 114(16). 3382–3391. 238 indexed citations

Bergmann, Manuela A., Barbara Eichhorst, Raymonde Busch, et al.. (2007). Early and Risk-Adapted Therapy with Fludarabine in High-Risk Binet Stage A CLL Patients Prolongs Progression Free Survival but Not Overall Survival: Results of the CLL1 Protocol of the German CLL Study Group (GCLLSG).. Blood. 110(11). 2038–2038. 5 indexed citations

10.

Bergmann, Manuela A., Barbara Eichhorst, Raymonde Busch, et al.. (2007). Prospective Evaluation of Prognostic Parameters in Early Stage Chronic Lymphocytic Leukemia (CLL): Results of the CLL1-Protocol of the German CLL Study Group (GCLLSG).. Blood. 110(11). 625–625. 17 indexed citations

11.

Bergmann, Manuela A., Maria Elisabeth Goebeler, Michael Herold, et al.. (2005). Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group.. PubMed. 90(10). 1357–64. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact